Gene and cell therapy developers at ASGCT 2027

May 3–7, 2027 Philadelphia, PA ~8k attendees Website

3 gene and cell therapy developers are at ASGCT 2027 — 3 with a booth in the exhibit hall. 3 of them have their own page in this guide. As of Oct 29, 2026.

All 120 organizations at ASGCT 2027 →

Showing 1–3 of 3 organizations
OrganizationASGCT 2027 Attendance
Gene and cell therapy developers
Gene therapy developer and Bayer subsidiary building AAV treatments for Parkinson's disease, heart failure and other rare and common conditions.
Booth
Exhibiting at Booth 422
Vyriad
Rochester, MN
Gene and cell therapy developers
Therapy developer engineering targeted virus platforms for in vivo gene therapy, genome editing and oncolytic virotherapy, with in-house preclinical and manufacturing capabilities.
Booth
Exhibiting at Booth 319
SB
Samyang Biopharm
Seongnam, South Korea
Gene and cell therapy developers
Korean drugmaker of anticancer drugs and absorbable sutures that is developing SENS, a polymer and lipid nanoparticle system delivering siRNA and mRNA to selected tissues.
Booth
Exhibiting at Booth 913

Explore the full ASGCT 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full ASGCT 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from gene and cell therapy developers

Tell us what you sell and we’ll find the people at these gene and cell therapy developers most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ASGCT 2027 by

Exhibit hall

Not affiliated with the American Society of Gene & Cell Therapy. Organization details are derived from ASGCT’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction